U.S. drugmaker Gilead Sciences consented to acquire CymaBay Therapeutics for $4.3 billion, adding a therapy for persistent liver illness to its portfolio. Portions of CymaBay were stopped in front of the declaration in premarket hours...
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a change of license for Comirnaty Omicron XBB.1.5 30 micrograms/dose (single dose vial) after it was found to meet safety, quality and manager standards of the United King
MedLern, the only medical education solution for hospitals and healthcare professionals, has entered into a strategic partnership with Asha Hospital, a healthcare facility accredited with NABH,
Sun Pharmaceutical Industries Limited has announced its inclusion in the SandP Global Sustainability Yearbook 2024. This yearbook aims to identify companies in each industry that have demonstrated a commitment to corporate sustainability.
BioInvent International AB (BioInvent), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, has announced a clinical supply agreement
The National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, has been awarded the Nelson Mandela Award for Health Promotion 2024 by the World Health Organization (WHO).
Humacyte, Inc., a clinical biotechnology foundation company developing bioengineered human tissues that can be transplanted commercially, has received in-principle approval of Humacyte's Biologics License Application (BLA)
In light of the growing threat of antimicrobial resistance (AMR), drug regulators have an important role in addressing the current global threat, largely due to the misuse and underuse of antibiotics. Dr Subhash C Mandal is the chairman of Regulatory
Vicore Pharma Holding AB, an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), has entered into an exclusive licensing agreement with Nippon S
Yatharth Hospital and Trauma Care Services announced the all-cash acquisition of Asian Fidelis Hospital, a multi-specialty hospital with 175 beds in Faridabad, for Rs 116 crore. Yatharth Clinic said it has gone into a conclusive concurrence with...
, CDSCO.jpg)
